Cardiovascular Drug Reviews |
|
- ACE Inhibitor Trandolapril Approved for Hypertension
- ACE Inhibitors and Birth Defects
- Adenosine for Supraventricular Arrhythmias
- Adverse Reactions due to Switch from Mibefradil and Beta-Blockers to CCBs - May/June 1998
- Amiodarone for Atrial Fibrillation
- Anagrelide for Essential Thrombocythemia
- Anger Triggers Heart Attacks in Some, But Aspirin May Reduce Risk
- Another Look at Calcium Channel Blockers
- Assessing Cholesterol-lowering Therapy
- Atacand for the Management of Hypertension - Oct 98
- Atorvastatin for Reduction of Elevated Cholesterol
- Atorvastatin is Better than Niacin for Patients with Combined Hyperlipidemia - Nov 98
- Atrial Fibrillation and Stroke: Aspirin or Warfarin?
- Calcium Antagonists and ACE Inhibitors Overused in Hypertension
- Calcium Channel Blockers and Cancer
- Calcium Channel Blockers and Increased Risk of Myocardial Infarction
- Calcium Channel Blockers Under Fire
- Carvedilol Approved for Hypertension
- Do We Need More Antihypertensive Agents?
- Cerivastatin for the Reduction of Elevated Total Cholesterol
- Enalapril-Felodipine ER for Hypertension
- Eptifibatide and Tirofiban Approved for Acute Coronary Syndromes - May/June 1998
- Expanded Indications Approved for Simvastatin: Preventing MI
- Dexrazoxane for Cardioprotection in Breast Cancer Therapy
- Fenoldopan for the Management of Acute Hypertensive Crisis
- Flosequinan for Congestive Heart Failure
- Fluvastatin for Hypercholesterolemia
- Flying and Barotrauma of the Middle Ear
- Focus On... Apolipoproteins
- Focus On... ACE Inhibitors in the 90s
- Focus On. . . Calcium blockers and the heart
- Focus On... Cardiology
- Focus On... Congestive Heart Failure
- Focus On... The Heart
- Focus On... Preventing Heart Disease
- Focus On... Stroke
- Focus On... Stroke as a Medical Emergency
- Focus On... The "Statins" and the Heart
- High Homocysteine Concentration Raises Risk of Carotid Stenosis in Elderly
- Hirudin: A Novel Anticoagulant
- Hydroxyurea for Sickle-cell Anemia
- Irbesartan Approved for Hypertension
- IV Magnesium Benefits Heart Failure Patients
- Kawasaki Disease: Unraveling the Mystery
- Lepirudin for Heparin-induced Thrombocytopenia Type II
- Lipid-Lowering Effects of Red Yeast Rice
- Light to Moderate Drinking of Modest Benefit to Women
- Losartan-induced Angioedema
- Low-dose Aspirin Safe During Pregnancy
- Magnesium
- Managing Ventricular Fibrillation in Patients with Silent Myocardial Ischemia
- Mibefradil for Hypertension and Angina Pectoris
- Murine Monoclonal Antibody c7E3-Fab Approved for Marketing
- Nicorandil for Angina Pectoris
- Nifedipine and False-positive Barium Enema Results
- Nisoldipine approved for hypertension
- Oprelvekin for Prevention of Severe Thrombocytopenia
- Perflubrons
- Plavix (clopidrogrel) for Unstable Angina and Stroke Prevention
- Preventing Coronary Disease with Beta- carotene
- Preventing Secondary Cardiac Attacks in Women - May/June 1998
- Preventing Stroke with Warfarin in Atrial Fibrillation
- Procainamide for Ventricular Arrhythmias
- Sildenafil for Erectile Dysfunction
- Sotalol for Severe Arrhythmias
- Take Charge, Take Heart -- Take Walnuts
- The homocysteine saga: B6, B12, and folate
- The Toxicity of Niacin
- t-PA and the Thrombolytic Debate
- Two New Biologicals from Miles: Recombinant Factor VIII and Aprotinin
- Two Thrombolytics Approved: Alteplase for Stroke, Reteplase for MI
- Verapamil COER-24 for angina and hypertension
- Vitamin E and the Risk of Coronary Artery Disease
- Why Aren't Thrombolytics Used More Often?
- Why Do Antiarrhythmics Induce Arrhthymias?
- Withdrawing Digoxin Carries Risk in ACE Inhibitor Use
| Medical Sciences Bulletin Contents | Publications Menu | PharmInfoNet Home Page |